Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02661776
What this trial is testing

The Change of NK Cell Activity After Head and Neck Cancer Surgery

Who this might be right for
The Patients Undergoing Head and Neck Surgery Including Tumor Removal and Reconstruction With Flap
Yonsei University 29
Not applicableUnknownNCT03294824
What this trial is testing

Non Randomized Comparative Study With Control

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 90
Not applicableNot Yet RecruitingNCT07409168
What this trial is testing

Multi-modal Fusion Model and Deep Learning for Predicting Treatment Response in NKTCL

Who this might be right for
Natural Killer/T-cell Lymphoma
Sun Yat-sen University 100
Testing effectiveness (Phase 2)UnknownNCT02544425
What this trial is testing

VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT)

Who this might be right for
Extranodal NK-T-Cell Lymphoma
Samsung Medical Center 27
Early research (Phase 1)UnknownNCT05665114
What this trial is testing

Natural Killer(NK) Cell Therapy in r/r AML

Who this might be right for
AML, Adult
Zhejiang University 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05464433
What this trial is testing

Tislelizumab Combined with Mitoxantrone Hydrochloride Liposome in Extranodal Natural Killer/T Cell Lymphoma

Who this might be right for
Extranodal Natural Killer T Cell Lymphoma
Sun Yat-sen University 46
Testing effectiveness (Phase 2)Study completedNCT01884688
What this trial is testing

UARK 2013-05 A Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma

Who this might be right for
Asymptomatic Multiple Myeloma
University of Arkansas 3
Early research (Phase 1)Study completedNCT04802070
What this trial is testing

Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

Who this might be right for
Sarcoma
Prof. Franca Fagioli 7
Early research (Phase 1)Study completedNCT04290546
What this trial is testing

CIML NK Cell in Head & Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckRecurrent Head and Neck Squamous Cell Carcinoma
Dana-Farber Cancer Institute 11
Early research (Phase 1)Study completedNCT03081780
What this trial is testing

Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML

Who this might be right for
Refractory Acute Myelogenous LeukemiaRelapsed Acute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 6
Not applicableStudy completedNCT02522585
What this trial is testing

P16 and Ki-67 Stainings and Natural Killer (NK) Cells in CIN-II Management

Who this might be right for
Cervical Cancer
Parc de Salut Mar 100
Testing effectiveness (Phase 2)Ended earlyNCT02100891
What this trial is testing

Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors

Who this might be right for
Ewing SarcomaNeuroblastomaRhabdomyosarcoma+2 more
Monica Thakar 15
Testing effectiveness (Phase 2)Study completedNCT02927925
What this trial is testing

Assess the Clinical Efficacy and Safety of Daratumumab in Participants With Relapsed or Refractory Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type

Who this might be right for
Lymphoma
Janssen Research & Development, LLC 32
Testing effectiveness (Phase 2)Study completedNCT01593670
What this trial is testing

Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 9
Not applicableStudy completedNCT03079544
What this trial is testing

Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients

Who this might be right for
Extranodal NK-T-Cell Lymphoma, Nasal Type
Rong Tao 665
Not applicableUnknownNCT01284712
What this trial is testing

Natural Killer Cells and Polycythemia Vera (Vaquez's Disease)

Who this might be right for
Polycythemia Vera
Assistance Publique Hopitaux De Marseille 27
Large-scale testing (Phase 3)Not Yet RecruitingNCT06255795
What this trial is testing

The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell Lymphoma

Who this might be right for
Extranodal Natural Killer T Cell Lymphoma
Ruijin Hospital 142
Early research (Phase 1)Study completedNCT02845999
What this trial is testing

Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab

Who this might be right for
Gastrointestinal Metastatic Cancer
Centre Hospitalier Universitaire de Besancon 9
Large-scale testing (Phase 3)Ended earlyNCT01916798
What this trial is testing

Intralipid Therapy for Women 35-40 Years With Positive Natural Killer Cells Undergoing Intracytoplasmic Sperm Injection (ICSI)

Who this might be right for
Infertility
Cairo University 200
Testing effectiveness (Phase 2)UnknownNCT02519114
What this trial is testing

Haploidentical Bone Marrow Stem Cell Transplantation in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Maastricht University Medical Center 24
Next Page